Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia.
Perreault S, Levinton C, Le Lorier J. Perreault S, et al. Among authors: le lorier j. Can J Clin Pharmacol. 2000 Autumn;7(3):144-54. Can J Clin Pharmacol. 2000. PMID: 11044760
Discrepancies between meta-analyses and subsequent large randomized, controlled trials.
LeLorier J, Grégoire G, Benhaddad A, Lapierre J, Derderian F. LeLorier J, et al. N Engl J Med. 1997 Aug 21;337(8):536-42. doi: 10.1056/NEJM199708213370806. N Engl J Med. 1997. PMID: 9262498
Do statins cause cancer? A meta-analysis of large randomized clinical trials.
Bjerre LM, LeLorier J. Bjerre LM, et al. Am J Med. 2001 Jun 15;110(9):716-23. doi: 10.1016/s0002-9343(01)00705-7. Am J Med. 2001. PMID: 11403756
Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed".
Bjerre LM, LeLorier J. Bjerre LM, et al. BMJ. 2000 Feb 19;320(7233):503-6. doi: 10.1136/bmj.320.7233.503. BMJ. 2000. PMID: 10678870 Free PMC article. Review. No abstract available.
The science of health technology assessment--clinical effectiveness of therapeutic interventions.
LeLorier J. LeLorier J. Can J Clin Pharmacol. 2001 Fall;8 Suppl A:21A-23A. Can J Clin Pharmacol. 2001. PMID: 11586374 Review.
Statins and cancer risk.
Karp I, Behlouli H, Lelorier J, Pilote L. Karp I, et al. Am J Med. 2008 Apr;121(4):302-9. doi: 10.1016/j.amjmed.2007.12.011. Am J Med. 2008. PMID: 18374689
Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
Blais L, Sheehy O, St-Hilaire JM, Bernier G, Godfroid P, LeLorier JJ. Blais L, et al. Pharmacoeconomics. 2005;23(5):493-503. doi: 10.2165/00019053-200523050-00008. Pharmacoeconomics. 2005. PMID: 15896100
Use of Continuous Exposure Variables when Examining Dose-Dependent Pharmacological Effects - Application to the Association between Exposure to Higher Statin Doses and the Incidence of Diabetes.
Guertin JR, Rahme E, LeLorier J. Guertin JR, et al. J Popul Ther Clin Pharmacol. 2017 Jan 1;24(1):5-15. doi: 10.22374/1710-6222.24.1.1. J Popul Ther Clin Pharmacol. 2017. PMID: 28186711
Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care.
Farahani P, Levine M, Gaebel K, LeLorier J, Perrault S, Gillis J, Soon J. Farahani P, et al. Clin Invest Med. 2007;30(2):E63-9. doi: 10.25011/cim.v30i2.981. Clin Invest Med. 2007. PMID: 17716543
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.
Guertin JR, Rahme E, Dormuth CR, LeLorier J. Guertin JR, et al. BMC Med Res Methodol. 2016 Feb 19;16:22. doi: 10.1186/s12874-016-0119-1. BMC Med Res Methodol. 2016. PMID: 26891796 Free PMC article.
152 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback